Insider Buying: SomnoMed Limited (ASX:SOM) Insider Acquires 25,593 Shares of Stock

SomnoMed Limited (ASX:SOM) insider Karen Borg acquired 25,593 shares of the business’s stock in a transaction dated Monday, September 9th. The shares were purchased at an average price of A$0.42 ($0.28) per share, with a total value of A$10,749.06 ($7,166.04).

SomnoMed Price Performance

The company has a current ratio of 1.76, a quick ratio of 1.05 and a debt-to-equity ratio of 14.93.

SomnoMed Company Profile

SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral appliances for the treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. Its flagship product SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea.